share_log

40 Stocks Moving In Wednesday's Mid-Day Session

40 Stocks Moving In Wednesday's Mid-Day Session

周三午盘，40只股票走势震荡
Benzinga Real-time News ·  2021/11/24 12:02

Gainers

赢家

  • Biofrontera Inc. (NASDAQ:BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
  • Longeveron Inc. (NASDAQ:LGVN) gained 48.1% to $25.50 after tumbling 39% on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
  • Ocuphire Pharma, Inc. (NASDAQ:OCUP) jumped 38% to $4.80 after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol Eye Drops in the reversal of pharmacologically-induced mydriasis.
  • Better Therapeutics, Inc. (NASDAQ:BTTX) shares gained 29% to $8.32 after Chardan Capital initiated coverage on the stock with a Buy rating and a $17 price target.
  • Bridgeline Digital, Inc. (NASDAQ:BLIN) jumped 23.5% to $3.43.
  • Grom Social Enterprises, Inc. (NASDAQ:GROM) gained 23.5% to $2.78. Grom Social Enterprises disclosed that its newest division, Curiosity Ink Media, unwrapped Santa.com.
  • Benessere Capital Acquisition Corp. (NASDAQ:BENE) jumped 21.3% to $12.34. eCombustible Energy will merge with Benessere Capital Acquisition Corp. in a $805 million deal.
  • Spark Networks SE (NYSE:LOV) gained 15% to $3.0699. Spark Networks 10% owner Osmium Diamond Lp acquired a total of 1654197 shares at an average price of $2.51.
  • Local Bounti Corporation (NYSE:LOCL) jumped 14.8% to $9.20.
  • BIOLASE, Inc. (NASDAQ:BIOL) rose 14.4% to $0.4810 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit deal.
  • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) gained 12.6% to $3.83. Reviva Pharmaceuticals recently posted a Q3 loss of $0.12 per share.
  • Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 12.5% to $3.5780 after the company reported Q4 2021 and FY21 revenue was higher year over year.
  • Pure Storage, Inc. (NASDAQ:PSTG) rose 10.8% to $30.23 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY22 sales guidance above estimates.
  • Golden Ocean Group Limited (NASDAQ:GOGL) rose 9% to $8.71 after reporting Q3 results.
  • HP Inc. (NYSE:HPQ) rose 9% to $35.10 after the company reported better-than-expected results for its fourth quarter and issued strong earnings forecast for the current quarter.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 6.1% to $3.31.
  • Biofrontera Inc.纳斯达克(Standard Chartered Bank：BFRI)股价上涨109.5%，至5.51美元，此前罗斯资本对该股的评级为买入，目标价为20美元。
  • 隆格韦隆公司(Longeveron Inc.)纳斯达克(Sequoia Capital：LGVN)在周二暴跌39%后，上涨48.1%，至25.5美元。该公司上周宣布，FDA授予Lomecel-B治疗左心发育不良综合征的罕见儿科疾病称号。
  • 奥克菲尔制药公司(Ocuphire Pharma，Inc.)纳斯达克(Starbucks：OCUP)股价上涨38%，至4.8美元，此前该公司宣布，首批受试者已参加MIRA-3期3期关键试验，评估尼索尔滴眼液逆转药物性散瞳的作用。
  • Better Treateutics，Inc.纳斯达克(Standard Chardan Capital：BTTX)股价上涨29%，至8.32美元，此前查尔丹资本对该股的评级为买入，目标价为17美元。
  • Bridgeline Digital，Inc.纳斯达克(BLIN：BLIN)跳涨23.5%，报3.43美元。
  • 格罗姆社会企业公司纳斯达克(Starbucks：Grom)上涨23.5%，至2.78美元。格罗姆社会企业(Grom Social Enterprise)透露，其最新部门好奇号墨水传媒(Curiity Ink Media)解开了Santa.com。
  • 贝内斯尔资本收购公司纳斯达克(Sequoia Capital：BENE)跳涨21.3%，报12.34美元。ECombusable Energy将与Benessere Capital Acquisition Corp.合并，交易金额为8.05亿美元。
  • 星火网络SE(纽约证券交易所股票代码：LOV)上涨15%，至3.0699美元。星火网络10%的持有者欧司曼钻石有限责任公司以2.51%的平均价格收购了总计1654197股。
  • 当地邦蒂公司(纽约证券交易所代码：Locl)股价上涨14.8%，至9.20美元。
  • Biolase，Inc.纳斯达克(Sequoia Capital：BIOL)股价上涨14.4%，至0.4810美元，此前纳斯达克批准该公司延期180天，以满足最低投标价格要求。该公司还达成了优惠的信贷交易。
  • Reviva制药控股公司(Reviva PharmPharmticals Holdings，Inc.)纳斯达克(Sequoia Capital：RVPH)上涨12.6%，至3.83美元。Reviva PharmPharmticals最近公布第三季度每股亏损0.12美元。
  • Engine Gaming and Media，Inc.纳斯达克(GAME：GAME)股价上涨12.5%，至3.5780美元，此前该公司公布2021年第四季度和21财年营收同比增长。
  • Pure Storage，Inc.纳斯达克(Sequoia Capital：PSTG)股价上涨10.8%，至30.23美元，此前该公司公布了好于预期的第三季度每股收益和销售业绩，并发布了高于预期的第四季度和22财年销售指引。
  • 金海集团有限公司纳斯达克(GOGL：GOGL)公布第三季度财报后，股价上涨9%，至8.71美元。
  • 惠普公司惠普(NYSE：HPQ)上涨9%，报35.10美元，此前该公司公布第四季业绩优于预期，并发布强劲的当前季度获利预估。
  • 美物科技有限公司纳斯达克(Sequoia Capital：WNW)股价上涨6.1%，至3.31美元。


Check out these big penny stock gainers and losers


看看这些微不足道的股票赢家和输家

Losers

失败者

  • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 34.3% to $4.79 after jumping over 80% on Tuesday.
  • Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares dipped 30.9% to $1.7699 after jumping around 105% on Tuesday.
  • Pasithea Therapeutics Corp. (NASDAQ:KTTA) declined 30.2% to $3.9100. Pasithea Therapeutics priced its 8.68 million share private placement at $3.50 per share.
  • Nordstrom, Inc. (NYSE:JWN) shares fell 28.5% to $22.81 after the company reported worse-than-expected Q3 sales results. Jefferies downgraded Nordstrom from Buy to Hold and lowered the price target from $48 to $30.
  • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 26.1% to $1.7294 after jumping over 75% on Tuesday.
  • Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 25.4% to $12.70. Aptevo Therapeutics shares climbed 163% on Tuesday after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 23.6% to $7.64 after surging over 40% on Tuesday.
  • The Gap, Inc. (NYSE:GPS) fell 21.5% to $18.44 after the company reported worse-than-expected Q3 EPS and sales results and cut FY21 adjusted EPS guidance below estimates.
  • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 21.5% to $4.5001. Clarus Therapeutics shares jumped 43% on Tuesday after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
  • iSpecimen Inc. (NASDAQ:ISPC) fell 21% to $10.42. iSpecimen shares jumped over 48% on Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • Outlook Therapeutics, Inc. (NASDAQ:OTLK) fell 20.5% to $1.24 after the company reported a $10 million bought deal offering of common stock.
  • Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 19.5% to $6.27. Gracell Biotechnologies shares gained 22% on Tuesday after the company reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
  • Anaplan, Inc. (NYSE:PLAN) shares fell 18.8% to $42.28 after the company reported Q3 earnings results. Piper Sandler downgraded Anaplan from Overweight to Neutral and lowered the price target from $77 to $48.
  • Kura Oncology, Inc. (NASDAQ:KURA) declined 16% to $13.95 after the company announced the FDA placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold.
  • Noah Holdings Limited (NYSE:NOAH) dropped 15.7% to $37.12 following Q3 results. JP Morgan downgraded Noah Holdings from Overweight to Neutral and announced a $50 price target.
  • MediciNova, Inc. (NASDAQ:MNOV) shares fell 14.7% to $3.7689 after surging 44% on Tuesday.
  • Autodesk, Inc. (NASDAQ:ADSK) shares fell 14.6% to $259.28. Autodesk reported upbeat results for its third quarter, but issued disappointing guidance. Autodesk said it sees Q4 revenue of $1.185 billion to $1.2 billion and non-GAAP earnings of $1.41 to $1.47 per share.
  • Viomi Technology Co., Ltd (NASDAQ:VIOT) slipped 14.2% to $3.50 following Q3 results.
  • NerdWallet, Inc. (NASDAQ:NRDS) dropped 13% to $22.10. The company recently priced its IPO at $4 per share.
  • Nuvation Bio Inc. (NYSE:NUVB) fell 12.3% to $8.10.
  • TDCX Inc. (NYSE:TDCX) dropped 10.8% to $20.19 following Q3 results.
  • Dillard's, Inc. (NYSE:DDS) fell 9.2% to $372.59.
  • Abercrombie & Fitch Co. (NYSE:ANF) fell 6.4% to $38.49. Abercrombie & Fitch recently reported third-quarter FY21 sales growth of 10% year-on-year, to $905.16 million, beating the analyst consensus of $896.86 million.
  • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 6.4% to $6.15 after the company received anticipated letter from Nasdaq regarding form 10-Q filing.
  • 瓦隆制药公司纳斯达克(Sequoia Capital：VLON)周二跳涨逾80%后下跌34.3%，至4.79美元。
  • 夸里根治疗公司(Qualigen Treateutics，Inc.)纳斯达克(Starbucks：QLGN)股价周二跳涨约105%，至1.7699美元，跌幅为30.9%。
  • 帕西娅治疗公司(Pasithea Treateutics Corp.)纳斯达克(KTTA：KTTA)下跌30.2%，至3.9100美元。帕西娅治疗公司(Pasithea Treeutics)将其868万股私募定价为每股3.50美元。
  • 诺德斯特龙公司(纽约证券交易所代码：JWN)股价下跌28.5%，至22.81美元，此前该公司公布的第三季度销售业绩逊于预期。Jefferies将诺德斯特龙的评级从买入下调至持有，并将目标价从48美元下调至30美元。
  • Petros制药公司纳斯达克(Sequoia Capital：PTPI)周二暴跌26.1%，报1.7294美元，盘中一度跃升逾75%.
  • Aptevo治疗公司纳斯达克(Alipay：APVO)跌25.4%，报12.7美元。Aptevo治疗公司股价周二上涨163%，此前该公司宣布了评估APVO436治疗AML的1b期扩大试验的临床更新。到目前为止观察到的初步数据包括一次完全缓解。
  • Esperion治疗公司纳斯达克(Sequoia Capital：ESPR)股价周二飙升逾40%后，下跌23.6%，至7.64美元。
  • The Gap，Inc.(纽约证券交易所股票代码：GPS)股价下跌21.5%，至18.44美元，此前该公司公布的第三季度每股收益和销售业绩逊于预期，并将21财年调整后每股收益指引下调至低于预期。
  • 克拉鲁斯治疗控股公司(Clarus Treateutics Holdings，Inc.)纳斯达克(Starbucks：CRXT)股价下跌21.5%，至4.5001美元。克拉鲁斯治疗公司(Clarus Treeutics)周二股价上涨43%，此前该公司获得了一项名为“口服睾酮酯配方和治疗睾酮缺乏症的方法”的美国专利。
  • ISpecimen Inc.纳斯达克(Sequoia Capital：ISPC)下跌21%，至10.42美元。在宣布签约支持新冠肺炎新的高级研究后，iSpecimen的股价周二上涨超过48%，该公司宣布已经签约支持微博的新的高级研究，寻求对微博的传播性、变种、结果和在多个人群中测试有效性的见解。
  • Outlook治疗公司纳斯达克(Starbucks：OTLK)股价下跌20.5%，至1.24美元，此前该公司公布以1,000万美元买入普通股。
  • 亘喜生物(Sequoia Capital Inc.)纳斯达克(GRCL：GRCL)跌19.5%，报6.27美元。亘喜生物周二股价上涨22%，此前该公司报道称，其高级管理团队成员打算在未来3个月内利用个人资金在公开市场购买高达200万美元的公司美国存托凭证。
  • Anaplan，Inc.(纽约证券交易所股票代码：PLAN)股价下跌18.8%，至42.28美元，此前该公司公布了第三季度收益业绩。Piper Sandler将Anaplan评级从加码下调至中性，目标价从77美元下调至48美元。
  • 库拉肿瘤公司纳斯达克(KURA)股价下跌16%，至13.95美元，此前该公司宣布美国食品和药物管理局(FDA)将KO-539在复发或难治性急性髓细胞白血病(AML)患者中的KOMET-001b期研究部分临床搁置。
  • 诺亚财富有限公司(纽约证券交易所股票代码：NOAH)第三季度财报公布后，股价下跌15.7%，至37.12美元。(投行观点)摩根大通将诺亚财富评级从加码下调至中性，并宣布目标价为50美元
  • MediciNova，Inc.纳斯达克(Sequoia Capital：MNOV)股价周二大涨44%后，下跌14.7%，至3.7689美元。
  • 欧特克公司纳斯达克(Sequoia Capital：ADSK)股价下跌14.6%，至259.28美元。欧特克公布了乐观的第三季度业绩，但发布了令人失望的指引。欧特克表示，预计第四季度营收为11.85亿至12亿美元，非GAAP每股收益为1.41至1.47美元。
  • 云米科技股份有限公司纳斯达克(Sequoia Capital：VIOT)第三季度财报公布后，股价下跌14.2%，至3.5美元。
  • NerdWallet，Inc.纳斯达克(Starbucks：NRDS)下跌13%，至22.10美元。该公司最近将首次公开募股(IPO)定价为每股4美元。
  • Nuvation Bio Inc.(纽约证券交易所股票代码：NUVB)下跌12.3%，至8.10美元。
  • TDCX Inc.(纽约证券交易所代码：TDCX)在第三季度财报公布后下跌10.8%，至20.19美元。
  • 迪拉德公司(Dillard‘s，Inc.)(纽约证券交易所代码：DDS)下跌9.2%，至372.59美元。
  • Abercrombie&Fitch Co.(纽约证券交易所代码：ANF)下跌6.4%，至38.49美元。Abercrombie&Fitch最近公布，2011财年第三季度销售额同比增长10%，至9.0516亿美元，超出分析师一致预期的8.9686亿美元。
  • 法拉第未来智能电气公司。纳斯达克(Sequoia Capital：FFIE)股价下跌6.4%，至6.15美元，此前该公司收到纳斯达克有关10-Q表格申报的预期信函。
声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发